Kircik L - Search Results

1

Interleukin 23p19 inhibitors in chronic plaque psoriasis with focus on mirikizumab: A narrative review.

Salimi S, Yamauchi PS, Thakur R, Weinberg JM, Kircik L, Abdelmaksoud A, Wollina U, Lotti T, Sharma A, Grabbe S, Goldust M. Salimi S, et al. Among authors: kircik l. Dermatol Ther. 2020 Jul;33(4):e13800. doi: 10.1111/dth.13800. Epub 2020 Jul 7. Dermatol Ther. 2020. PMID: 32530083 Review.

2

Successful Treatment of Refractory Plaque-Type Psoriasis and Psoriatic Arthritis With Guselkumab and Adalimumab Combination Therapy: A Case Report.

Rathod D, Weinberg JM, Yamauchi PS, Kircik LH, Wollina U, Lotti T, Goldust M. Rathod D, et al. J Drugs Dermatol. 2019 Apr 1;18(4):394-396. J Drugs Dermatol. 2019. PMID: 31017383

3

Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study.

Dehpouri T, Rokni GR, Narenjbon NA, Goldust M, Yamauchi PS, Wollina U, Lotti T, Kircik L, Lernia VGD, Sonthalia S, Vojvodic A, Szepietowski J, Bahadoran P, Errichetti E, Cantisani C, Atzori L, Rezaee E, Kutlubay Z, Engin B, Nisticò S, Damiani G, Conic RRZ, Goren A, Čabrijan L, Tchernev G. Dehpouri T, et al. Among authors: kircik l. Dermatol Reports. 2019 May 9;11(1):7965. doi: 10.4081/dr.2019.7965. eCollection 2019 Jan 23. Dermatol Reports. 2019. PMID: 31210916 Free PMC article.

4

Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients With Psoriasis.

Green LJ, Yamauchi PS, Kircik LH. Green LJ, et al. J Drugs Dermatol. 2019 Aug 1;18(8):776-788. J Drugs Dermatol. 2019. PMID: 31424708 Review.

5

Necrobiosis Lipoidica Mimicking Cutaneous Sarcoidosis Finally Treated With an Intralesional Injection of Corticosteroid: A Case Report.

Goldust M, Rahmatpour Rokni G, Weinberg JM, Kircik L, Bagot M. Goldust M, et al. Among authors: kircik l. J Drugs Dermatol. 2020 Jan 1;19(1):92-94. doi: 10.36849/JDD.2020.4675. J Drugs Dermatol. 2020. PMID: 32023016

6

Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion for Moderate-to-Severe Psoriasis: Pooled Phase 3 Analysis of Lower Extremities.

Tyring S, Kircik LH, Yamauchi P, Jacobson A, Lin T. Tyring S, et al. J Drugs Dermatol. 2020 Apr 1;19(4):389-396. doi: 10.36849/JDD.2020.4958. J Drugs Dermatol. 2020. PMID: 32272516 Clinical Trial.

7

Pityriasis Lichenoides Chronica in a Patient With Ankylosing Spondylitis Treated With Etanercept.

Goldust M, Weinberg JM, Kircik LH, Sonthalia S, Di Lernia V, Rathod D. Goldust M, et al. J Drugs Dermatol. 2020 May 1;19(5):560-561. J Drugs Dermatol. 2020. PMID: 32484616

8

Pityriasis Lichenoides Chronica in a Patient With Ankylosing Spondylitis Treated With Etanercept.

Goldust M, Weinberg JM, Kircik LH, Sonthalia S, Di Lernia V, Rathod D. Goldust M, et al. J Drugs Dermatol. 2020 Mar 1;19(3):324-325. J Drugs Dermatol. 2020. PMID: 32550684

9

PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in Psoriasis.

Stein Gold L, Alonso-Llamazares J, Lacour JP, Warren RB, Tyring SK, Kircik L, Yamauchi P, Lebwohl M; PSO-LONG Trial Investigators. Stein Gold L, et al. Among authors: kircik l. Adv Ther. 2020 Nov;37(11):4730-4753. doi: 10.1007/s12325-020-01497-6. Epub 2020 Sep 23. Adv Ther. 2020. PMID: 32965655 Free PMC article.

10

Antihistamines in Psoriasis.

Shivakumar S, Mueller SM, Yamauchi PS, Weinberg JM, Kircik L, Szepietowski JC, Goldust M. Shivakumar S, et al. Among authors: kircik l. J Drugs Dermatol. 2021 Aug 1;20(8):844-847. doi: 10.36849/JDD.5966. J Drugs Dermatol. 2021. PMID: 34397204 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

354 results

Search Page